CUMULATIVE SAFETY ASSESSMENT OF THE TAKEDA TETRAVALENT DENGUE VACCINE CANDIDATE IN PARTICIPANTS 4 TO 60 YEARS OLD

被引:0
|
作者
Patel, Sanjay S. [1 ]
Rauscher, Martina [1 ]
Peng, Hang [2 ]
机构
[1] Takeda Pharmaceut, Zurich, Switzerland
[2] Takeda Pharmaceut Int Inc, Cambridge, MA USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1290
引用
收藏
页码:413 / 413
页数:1
相关论文
共 50 条
  • [1] PROGRESS IN DEVELOPMENT OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE
    Tricou, Vianney
    Saez-Llorens, Xavier
    Yu, Delia
    Rivera, Luis
    Borkowski, Astrid
    Wallace, Derek
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 194 - 194
  • [2] TAKEDA'S TETRAVALENT DENGUE VACCINE (TDV) CANDIDATE PROGRESSES TO PHASE III: SAFETY AND IMMUNOGENICITY OF TDV
    Wallace, Derek
    Tricou, Vianney
    Stinchcomb, Dan
    Amfo, Kwasi
    Borkowski, Astrid
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 20 - 20
  • [3] EFFICACY AND SAFETY OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) AFTER 4.5 YEARS OF FOLLOW-UP: RESULTS FROM PARTICIPANTS IN ASIA
    Green, A.
    Biswal, S.
    Lloyd, E.
    Tricou, V.
    Folschweiller, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S11 - S11
  • [4] Takeda's candidate Tetravalent Dengue Vaccine (TDV) - Progress to Phase 3
    Goh, Choo-Beng
    Brett, Jeremy
    Wallace, Derek
    Borkowski, Astrid
    Dean, Hansi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S36 - S36
  • [5] Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by Aedes albopictus
    Dietrich, Elizabeth A.
    Ong, Yee Tsuey
    Stovall, Janae L.
    Dean, Hansi
    Huang, Claire Y. -H.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 1423 - 1427
  • [6] COMPREHENSIVE ANALYSIS OF THE IMMUNE RESPONSE ELICITED BY TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE
    Dean, Hansi
    Egan, Michael
    Wallace, Derek
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 242 - 242
  • [8] MAGNITUDE AND FUNCTIONALITY OF NS1-SPECIFIC ANTIBODY RESPONSE ELICITED BY TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE
    Glasner, Dustin
    Sharma, Mayuri
    Watkins, Heather
    Kassa, Yoseph
    Braun, Ralph
    Egan, Michael
    Dean, Hansi
    Harris, Eva
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 509 - 509
  • [9] Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines
    Santos, Jaime
    Montellano, May Emmeline
    Solante, Rontgene
    Perreras, Nicole
    Meyer, Stephanie
    Toh, Myew-Ling
    Zocchetti, Celine
    Vigne, Claire
    Mascarenas, Cesar
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (09) : 856 - 863
  • [10] Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)
    Rivera, Luis
    Biswal, Shibadas
    Saez-Llorens, Xavier
    Reynales, Humberto
    Lopez-Medina, Eduardo
    Borja-Tabora, Charissa
    Bravo, Lulu
    Sirivichayakul, Chukiat
    Kosalaraksa, Pope
    Martinez Vargas, Luis
    Yu, Delia
    Watanaveeradej, Veerachai
    Espinoza, Felix
    Dietze, Reynaldo
    Fernando, LakKumar
    Wickramasinghe, Pujitha
    Duarte Moreira Jr, Edson
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Luz, Kleber
    Venancioda Cunha, Rivaldo
    Rauscher, Martina
    Zent, Olaf
    Liu, Mengya
    Hoffman, Elaine
    LeFevre, Inge
    Tricou, Vianney
    Wallace, Derek
    Alera, Maria Theresa
    Borkowski, Astrid
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 107 - 117